2017 saw a spike in investor confidence and complacency, as volatility fell significantly and appetite for risk fueled many stocks higher. Chad Morganlander, Portfolio Manager at Washington Crossing Advisors, was with us to discuss whether he expects more of the same for the year ahead.
Morganlander says we are at point in the market cycle where global growth is predictable in the short-term. His firm is somewhat optimistic, but aware that valuations are becoming quite stretched, he adds. Morganlander believes markets are entering a period of low growth for next several years, predicting a 4% to 6% return in U.S. equities.
One of Morganlander's top picks for the year is Hershey’s. He suggests investors stick with "big and boring" companies. With Hershey's, investors can go to sleep for 3-5 years and wake up with tremendous returns, according to Morganlander. Hershey's has also entered a bid for Nestle's U.S. confectionary business, which includes brands such as Butterfunger and Baby Ruth. The potential acquisition is not baked in to Washington Crossing Advisor's outlook. He also recommends shares of Hormel Foods and Dr Pepper Snapple.
Meridith McGraw, White House Reporter at The Wall Street Journal, breaks down Trump’s $200M ballroom plan, D.C. police tensions, and the future of MAGA.
After years of being told that red wine was good for heart health, more Americans appear to be heeding warnings that even moderate alcohol consumption can be unhealthy.
Amazon is now rolling out a service where its Prime members can order their blueberries and milk at the same time as their batteries and other basic items.
Dr. Richard Besser, President & CEO of the Robert Wood Johnson Foundation and former CDC acting director, unpacks the impact of RFK's mRNA funding cuts.
Jessica Inskip, Director of Investor Research at StockBrokers.com and host of MarketMakeHer, unpacks earnings, market outlook, and what history says is next.
